Guoping Li, Ph.D., of the Department of Anesthesia, Critical Care & Pain Medicine at Massachusetts General Hospital, is the ...

Researchers at the University of Pittsburgh have identified a new way of predicting whether a kidney donor and recipient are ...

For people with kidney failure, home dialysis can offer more freedom and better quality of life. So what’s stopping the NHS ...

A trial tested the efficacy of corticosteroids in reducing interstitial fibrosis after kidney transplantation in low-risk patients.

The primary endpoint was functional immune tolerance, defined as off all immunosuppressive drugs 24 months after ...

Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

Investigators studied whether changes in renal hyperfiltration status affects patient outcomes using a Korean population cohort of more than 4.5 million patients.

In a real-world setting, the administration of oral semaglutide leads to a significant reduction in the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and albuminuria.

Ten weeks after a New England man received a kidney transplant, he went into respiratory failure and shock — thanks to an extensive parasitic worm infection, according to his medical team. The ...

Chronic kidney disease (CKD)-related anaemia is a common and debilitating complication, primarily due to a relative deficiency ...

Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with AMI.

The incidence of renal cell carcinoma among the included patients with Fabry disease was 15 times higher than in the general population.